Amyris to Begin Selling Biofene Online at Farnesene.net
April 04 2014 - 7:00AM
Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biology innovator
and renewable products company, today announced it has begun
selling Biofene®, Amyris's brand of farnesene, a long-chain
branched hydrocarbon, online at farnesene.net. By making initial
quantities of its building block molecule available to a broader
audience, Amyris seeks to expand Biofene's use beyond the
commercial applications the Company and its partners are already
developing.
"We want to make our renewable hydrocarbon building block
molecule widely available to create new products and applications.
We expect to accelerate Amyris's commercialization by simplifying
access to high-purity, renewable farnesene," said John Melo,
Amyris's President & CEO.
Amyris is now selling Biofene through its website in 1 kilogram
lot sizes (about a quarter of a gallon). Biofene
(trans-beta-Farnesene, E,E-Farnesene, CAS 18794-84-8) is a 15
carbon, long-chain, branched, unsaturated hydrocarbon manufactured
by the fermentation of plant-sugars using Amyris's engineered
microbes.
"This innovative approach is complementary to our current
strategy for growing existing products – such as our Neossance™
Squalane, renewable fuels, base oils and monomers for the tire
industry, all of which are produced from our farnesene," concluded
Melo.
Biofene offers unique physical properties and chemical
reactivity for new materials and for a variety of applications,
including adhesives, surfactants, resins, coatings, vitamin
precursors, performance materials and crop protection. Farnesene is
an essential oil that is found in small quantities in some plants
such as apples, but Amyris has developed a proprietary technology
to produce farnesene at industrial scale.
Visit farnesene.net today for additional information and special
introductory pricing.
About Amyris
Amyris is an integrated renewable products company focused on
providing sustainable alternatives to a broad range of
petroleum-sourced products. Amyris uses its industrial synthetic
biology platform to convert plant sugars into a variety of
molecules -- flexible building blocks that can be used in a wide
range of products. Amyris is commercializing these products both as
No Compromise® renewable ingredients in cosmetics, flavors and
fragrances, polymers, lubricants and consumer products, and also as
No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a
subsidiary of Amyris, oversees the establishment and expansion of
Amyris' production in Brazil. More information about Amyris is
available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical facts could be
deemed to be forward-looking statements. These forward-looking
statements include, among other things, statements regarding future
events (such as expansion of commercial applications for Biofene,
and creation of new products from, and acceleration of
commercialization efforts for, Biofene) that involve risks and
uncertainties. These statements are based on management's current
expectations and actual results and future events may differ
materially due to risks and uncertainties, including those
associated with potential complications in the launch of a new
product sales initiative, uncertainty regarding demand levels for
Biofene, Amyris's reliance on third parties to achieve its goals,
and other risks detailed in the "Risk Factors" section of Amyris'
quarterly report on Form 10-K filed on April 2, 2014. Amyris
disclaims any obligation to update information contained in these
forward-looking statements whether as a result of new information,
future events, or otherwise.
Amyris, the Amyris logo, Biofene, Neossance, and No Compromise
are trademarks or registered trademarks of Amyris, Inc.
CONTACT: Amyris, Inc.
Media & Investor Relations
info@amyris.com
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Apr 2024 to May 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From May 2023 to May 2024